USER TALK: Multi-omics in Clinical Cancer Diagnostics: The Importance of RNA-Seq

WEBINAR: Multi-omics in clinical cancer diagnostics: the importance of RNA-Seq

ABSTRACT:
Colorectal cancer is the third most frequently diagnosed cancer after lung and breast cancer and, unlike these agents, has relatively few stratified molecular targets for therapy due to the complex, heterogenous nature of the disease.
In this webinar, Andrew Beggs of the University of Birmingham discusses a project that performed stratified analysis of patients as a pre-pilot for the 100,000 Genomes project. His team performed whole-genome sequencing on fresh samples and, as proof of principle, 3’ RNA-seq on matched formalin-fixed, paraffin-embedded samples.
Dr. Beggs will demonstrate that by combining WGS and RNA-seq, many interesting insights can be gained into the underlying disease processes in colorectal cancer, allowing identification of new targets for therapy and disease stratification.
Dr. Lukas Paul, Senior Manager of Scientific Affairs discusses the acceleration of gene expression profiling projects with the massive multiplexing of 3’ mRNA-Seq libraries.

SPEAKER:
Andrew Beggs
Professor of Cancer Genetics & Surgery, Institute of Cancer and Genomic Sciences
University of Birmingham

Lukas Paul
Senior Manager of Scientific Affairs
Lexogen

FOR MORE INFORMATION:

Learn more about QuantSeq 3‘ mRNA-Seq Library Prep Kit:

Learn more about QuantSeq-Pool Sample-Barcoded 3′ mRNA-Seq Library Prep Kit for Illumina:

Learn more about Lexogen products:

FOLLOW US: